跳至主要内容
临床试验/ACTRN12621000791831
ACTRN12621000791831招募中未知

Feasibility of Percutaneous Decannulation of Extracorporeal Membrane Oxygenation Using MANTA Vascular Closure Device in Adults

Antony Walton0 个研究点目标入组 20 人开始时间: 2021年6月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Deemed appropriate by the multi-disciplinary team discussion including ICU physician, cardiothoracic surgeon, vascular surgeon, and interventional cardiologist.
  • -Suitable vascular anatomy as established by vascular ultrasound.
  • -Suitable body habitus (body mass index >20kg/m2 and <40 kg/m2).

排除标准

  • -Non femoral ECMO.
  • -Thrombus in CFA/SFA .
  • -Track depth on ultrasound exceeding 7cm.
  • -Puncture site of arterial cannula close to bifurcation , or other unfavourable features such as heavily calcified CFA.
  • -Arterial re-cannulation cases.
  • -ECMO > 14 days in situ.
  • -Known bleeding disorder including thrombocytopenia (platelet count <50 000 cells/µL), thrombasthenia, haemophilia, von Willebrand disease.
  • -Cannula site infection.

研究者

发起方
Antony Walton

相似试验